Archivio delibere
Seduta del 02/03/2016
Delibera del 02 Marzo, n. 40 [file.pdf]
Autorizzazione allo studio “a multicenter randomized double blind, double dummy, parallel-group, active controllaed study to evaluate the efficacy and safety of finerenone compared to eplerenone on morbility and mortality in patients with chronic heart failure and reduced ejecton fraction after recent heart failure decompensation and additional risk factors either type 2 diabetes mellitus or chronic kidney disease or both. – finesse-hf”.
Autorizzazione allo studio “a multicenter randomized double blind, double dummy, parallel-group, active controllaed study to evaluate the efficacy and safety of finerenone compared to eplerenone on morbility and mortality in patients with chronic heart failure and reduced ejecton fraction after recent heart failure decompensation and additional risk factors either type 2 diabetes mellitus or chronic kidney disease or both. – finesse-hf”.
Data seduta:02/03/2016
In pubblicazione dal: 02/03/2016-al: 17/03/2016
In pubblicazione dal: 02/03/2016-al: 17/03/2016